Warburg for Warheads: Leveraging the Cybrexa Alphalex PDC for Antigen Agnostic Targeting of Tumor Cells

Time: 2:30 pm
day: Conference Day Two

Details:

  • Introducing how to use pHLIP peptides for tumor targeting
  • Reviewing the discovery and development of tumor microenvironment sensitive anticancer PDCs
  • Optimizing the Alphalex-payload linker for delivering two different cytotoxic warhead classes

Speakers: